We are live on
!
Find out more
SCCM
Schafer Cullen Capital Management Portfolio holdings
AUM
$491M
1-Year Est. Return
41.48%
This Fund
S&P 500
This Quarter
Est. Return
+4.22%
1 Year Est. Return
+41.48%
3 Year Est. Return
+28.44%
5 Year Est. Return
+53.22%
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$532M
(+5.2%)
Cap. Flow
+$41M
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
22.74%
Holding
356
New
34
Increased
102
Reduced
152
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$126M |
| 2 |
JPMorgan Chase
JPM
|
+$64.3M |
| 3 |
REXMY
REXAM PLC ADR - NEW
REXMY
|
+$45.1M |
| 4 |
CEO
CNOOC Limited
CEO
|
+$15.7M |
| 5 |
GSK
GSK
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dominion Energy
D
|
+$134M |
| 2 |
AstraZeneca
AZN
|
+$101M |
| 3 |
ABB
ABB Ltd
ABB
|
+$12.9M |
| 4 |
ConocoPhillips
COP
|
+$7.63M |
| 5 |
Johnson & Johnson
JNJ
|
+$7.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.3% |
| 2 | Energy | 10.99% |
| 3 | Consumer Staples | 9.11% |
| 4 | Technology | 8.91% |
| 5 | Financials | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UN
1
DELISTED
Unilever NV New York Registry Shares
UN
| $309M | 2.84% |
7,050,734
+32,737
| +0.5% | +$1.4M |
|
|
RDS.B
2
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $293M | 2.7% |
3,366,047
+17,298
| +0.5% | +$1.44M |
|
|
3
ConocoPhillips
COP
$147B
| $251M | 2.32% |
2,931,477
-97,994
| -3% | -$7.63M |
|
4
HSBC
HSBC
$355B
| $243M | 2.24% |
5,547,212
+150,509
| +3% | +$6.71M |
|
|
5
Johnson & Johnson
JNJ
$634B
| $241M | 2.22% |
2,301,046
-73,284
| -3% | -$7.41M |
|
6
Merck
MRK
$324B
| $240M | 2.21% |
4,339,770
-131,082
| -3% | -$7.15M |
|
7
Intel
INTC
$464B
| $227M | 2.09% |
7,336,146
-240,497
| -3% | -$6.59M |
|
8
BCE
BCE
$19.9B
| $225M | 2.08% |
4,964,263
-54,303
| -1% | -$2.45M |
|
9
Microsoft
MSFT
$2.84T
| $223M | 2.06% |
5,347,191
-132,545
| -2% | -$5.36M |
|
10
NextEra Energy
NEE
$187B
| $216M | 1.99% |
8,423,464
-268,748
| -3% | -$6.54M |
|
11
Altria Group
MO
$122B
| $208M | 1.92% |
4,956,081
-151,778
| -3% | -$6.11M |
|
12
Eli Lilly
LLY
$1.07T
| $207M | 1.91% |
3,332,654
-112,454
| -3% | -$6.71M |
|
13
Chevron
CVX
$388B
| $205M | 1.89% |
1,570,763
-3,238
| -0.2% | -$403K |
|
|
14
JPMorgan Chase
JPM
$939B
| $204M | 1.88% |
3,538,010
+1,143,418
| +48% | +$64.3M |
|
15
Cisco
CSCO
$450B
| $201M | 1.85% |
8,069,858
-189,990
| -2% | -$4.53M |
|
16
GE Aerospace
GE
$367B
| $195M | 1.8% |
1,547,242
-24,181
| -2% | -$3.08M |
|
|
RTN
17
DELISTED
Raytheon Company
RTN
| $186M | 1.71% |
2,013,705
-50,943
| -2% | -$4.94M |
|
|
DD
18
DELISTED
Du Pont De Nemours E I
DD
| $186M | 1.71% |
2,985,425
-33,966
| -1% | -$2.18M |
|
19
3M
MMM
$89B
| $185M | 1.7% |
1,542,241
-58,185
| -4% | -$6.83M |
|
20
AT&T
T
$165B
| $180M | 1.66% |
6,749,916
+53,080
| +0.8% | +$1.42M |
|
|
21
AstraZeneca
AZN
$263B
| $178M | 1.64% |
2,393,638
-1,392,175
| -37% | -$101M |
|
22
Philip Morris
PM
$301B
| $173M | 1.6% |
2,055,891
-24,931
| -1% | -$2.15M |
|
23
MetLife
MET
$61B
| $171M | 1.57% |
3,447,226
-11,016
| -0.3% | -$515K |
|
24
Vodafone
VOD
$34.9B
| $170M | 1.57% |
5,083,604
+107,040
| +2% | +$3.79M |
|
25
Travelers Companies
TRV
$80.8B
| $167M | 1.54% |
1,779,547
-50,443
| -3% | -$4.6M |
|
Similar funds
CNC
SRAM
PA
FBP
SGMP
RG
LFA
RHFI
Schafer Cullen Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Schafer Cullen Capital Management held 356 positions worth $10.8B, up 5.2% from $10.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Schafer Cullen Capital Management's Q2 2014 filing shows 34 new, 102 increased, 152 reduced and 20 closed positions. Its largest new stake was REXAM PLC ADR - NEW: 965,082 shares worth $45.1M. The largest sale was Dominion Energy, an estimated $134M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Energy and Consumer Staples.
- Schafer Cullen Capital Management's largest Q2 2014 buy was REXAM PLC ADR - NEW: 965,082 shares worth $45.1M.
- Schafer Cullen Capital Management added most to Pfizer in Q2 2014, an estimated $126M increase.
- Schafer Cullen Capital Management's biggest Q2 2014 reduction was Dominion Energy, cutting an estimated $134M.
- Schafer Cullen Capital Management fully exited Chunghwa Telecom in Q2 2014, selling an estimated $4.26M.
- Schafer Cullen Capital Management's ten largest holdings make up 23% of its $10.8B portfolio in Q2 2014.
- Schafer Cullen Capital Management opened 34 new positions and closed 20 in Q2 2014.
- Schafer Cullen Capital Management's portfolio value rose 5.2% quarter-over-quarter to $10.8B.
Based on Schafer Cullen Capital Management's 13F filing for Q2 2014, filed 11 Aug 2014.